Antinuclear antibody test: When to order?

American Journal of Medicine

Volumn 126, Issue 10, 2013, Pages

  Meroni, Pier Luigi ^a   Chan, Edward K L ^b   Tincani, Angela ^c   García De La Torre, Ignacio ^d   Andrade, Luis E C ^e  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY OF BRESCIA   (Italy)

^d HOSPITAL GENERAL DE OCCIDENTE   (Mexico)

^e Rheumatology Division   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; COMPLEMENT;

ANTIBODY SCREENING; AUTOIMMUNE DISEASE; COST BENEFIT ANALYSIS; DELAYED DIAGNOSIS; HUMAN; IMMUNOASSAY; LETTER; PHYSICIAN; PREDICTIVE VALUE; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR; SPONTANEOUS ABORTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIBODIES, ANTINUCLEAR; CONNECTIVE TISSUE DISEASES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE;

EID: 84884506335     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2013.04.022     Document Type: Letter

References (5)

1. A.M. Abeles, and M. Abeles The clinical utility of a positive antinuclear antibody test result Am J Med 126 2013 342 348
2. J. Savige, D. Gillis, and E. Benson International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA) Am J Clin Pathol 111 1999 507 513
3. H.A. Mariz, E.I. Sato, and S.H. Barbosa Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases Arthritis Rheum 63 2011 191 200
4. E.M. Tan, T.E. Feltkamp, and J.S. Smolen Range of antinuclear antibodies in "healthy" individuals Arthritis Rheum 40 1997 1601 1611
5. J. Yazdany, G. Schmajuk, and M. Robbins Choosing wisely: The American College of Rheumatology's top 5 list of things physicians and patients should question Arthritis Care Res 65 2013 329 339